China Fund Inc  

(Public, NYSE:CHN)   Watch this stock  
Find more results for Daniel A Kirby�
12.85
-0.03 (-0.23%)
Feb 12 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 12.72 - 12.98
52 week 12.50 - 22.24
Open 12.88
Vol / Avg. 12,984.00/34,593.00
Mkt cap 200.73M
P/E     -
Div/yield 0.21/1.66
EPS -0.54
Shares 15.68M
Beta 1.12
Inst. own 58%

Key stats and ratios

Q4 (Oct '15) 2015
Net profit margin -1066.14% -98.14%
Operating margin 70.31% 46.44%
EBITD margin - 46.44%
Return on average assets -41.77% -2.25%
Return on average equity -46.40% -2.44%
CDP Score - -

Address

Two Avenue De Lafayette, (02206-5049) PO Box 5049
BOSTON, MA 02111
United States - Map
+1-617-6622789 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

The China Fund, Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund’s objective is to achieve long-term capital appreciation through investment in companies and other entities with significant assets, investments, production activities, trading or other business interests in China. The Fund invests in commercial services and supplies, food products, health care, providers and services. Allianz Global Investors U.S. LLC (AllianzGI U.S.) is the Investment Manager for the Fund.

Officers and directors

Joe O. Rogers Ph.D. Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Joseph Quirk President
Age: 47
Bio & Compensation  - Reuters
Patrick J. Keniston Chief Compliance Officer
Age: 51
Bio & Compensation  - Reuters
Monique Labbe Treasurer
Age: 42
Bio & Compensation  - Reuters
Brian F. Link Secretary
Age: 43
Bio & Compensation  - Reuters
Linda C. Coughlin Director
Age: 63
Bio & Compensation  - Reuters
Gary L. French Director
Age: 64
Bio & Compensation  - Reuters
Richard Daniel Shore Director
Age: 54
Bio & Compensation  - Reuters
Michael F. Holland Independent Director
Age: 72
Bio & Compensation  - Reuters
William C. Kirby Independent Director
Age: 65
Bio & Compensation  - Reuters